Sadiqa Mahmood is currently the general manager and senior vice president of the life sciences business at Health Catalyst, which aims to be "the catalyst for massive, measurable, data-informed healthcare improvement."
She is a dental surgeon with a master’s degree from the Harvard School of Public Health, and her distinguished career includes work at the Dana-Farber Cancer Institute, Partners HealthCare System, and the Boston Medical Center.
Mahmood stands at the intersection of medicine, policy, technology, and analytics. She advises several healthcare organizations and global policymakers.
Health Catalyst has seen her spearhead tremendous growth in 18 months, with a customer base including regulators, top five contract research organizations, and top 40 biopharma groups.
“Dr. Mahmood lifts up our team members and leads by example. She is brilliant, bold, and a trailblazer,” remarked Trudy M. Sullivan, chief diversity, equity, and inclusion (DEI) officer at Health Catalyst.
Mahmood’s past achievements include overseeing the $104.5 million acquisition of the patient engagement platform Twistle.
At Dana Farber, she expanded an analytics program to executive leadership and front-line staff in several departments. Her help in developing a safety tool identifying high-risk patients on immunotherapy drugs led to the prevention of three hospital admissions per week.
At Partners, she expanded a clinical collaboration program from five departments to 21 departments, tangibly improving clinical care. She will receive a Career Achievement Award at the 2022 Women of Color STEM Conference in Detriot, MI. Click here to register.
